Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126454761 | 12645476 | 1 | I | 20150330 | 20160808 | 20160811 | 20160811 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065906 | BRISTOL MYERS SQUIBB | 35.26 | YR | M | Y | 97.50000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126454761 | 12645476 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 2 MG, QD | 21436 | 2 | MG | TABLET | QD | ||||||
| 126454761 | 12645476 | 2 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Unknown | UNK | U | 0 | INJECTION | ||||||||
| 126454761 | 12645476 | 3 | C | ATIVAN | LORAZEPAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126454761 | 12645476 | 4 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126454761 | 12645476 | 5 | C | LOXAPINE. | LOXAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126454761 | 12645476 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126454761 | 12645476 | 7 | C | DIVALPROEX | DIVALPROEX SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126454761 | 12645476 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126454761 | 12645476 | 9 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126454761 | 12645476 | 1 | Psychotic disorder |
| 126454761 | 12645476 | 2 | Product used for unknown indication |
| 126454761 | 12645476 | 3 | Product used for unknown indication |
| 126454761 | 12645476 | 4 | Product used for unknown indication |
| 126454761 | 12645476 | 5 | Product used for unknown indication |
| 126454761 | 12645476 | 6 | Product used for unknown indication |
| 126454761 | 12645476 | 7 | Product used for unknown indication |
| 126454761 | 12645476 | 8 | Glucose tolerance impaired |
| 126454761 | 12645476 | 9 | Sleep disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126454761 | 12645476 | Adverse event | |
| 126454761 | 12645476 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126454761 | 12645476 | 1 | 20080805 | 0 | ||
| 126454761 | 12645476 | 2 | 201512 | 0 | ||
| 126454761 | 12645476 | 3 | 2008 | 0 | ||
| 126454761 | 12645476 | 4 | 2008 | 0 |